Frequent loss of imprinting of the H19 and IGF-II genes in ovarian tumors

American Journal of Medical Genetics

Volumn 80, Issue 4, 1998, Pages 391-395

  Kirn, Hong Tae ^a   Choi, Bo Hwa ^b   Niikawa, Norio ^a   Lee Sung, Tae ^a   Chang, Sung Ik ^a  

^a Keimyung University   (South Korea)

^b NAGASAKI UNIVERSITY   (Japan)

Author keywords

Carcinogenesis; Genomic imprinting; H19; IGF2; Ovarian cancer

Indexed keywords

ARTICLE; CARCINOGENESIS; FEMALE; GENE LOSS; GENETIC LINKAGE; GENOME IMPRINTING; HUMAN; OVARY CANCER; OVARY TUMOR; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ALLELES; DNA, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; GENOMIC IMPRINTING; HUMANS; INSULIN-LIKE GROWTH FACTOR II; MUSCLE PROTEINS; OVARIAN NEOPLASMS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RNA, UNTRANSLATED;

EID: 0031770813     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(19981204)80:4<391::AID-AJMG16>3.0.CO;2-H     Document Type: Article

References (31)

1. Berchuck A, Carney M (1997): Human ovarian cancer of the surface epithelium. Biochem Pharmacol 54:541-544.
2. Brannan CI, Dees EC, Ingram ES, Tilghman SM (1990): The product of the H19 gene may function as an RNA. Mol Cell Biol 10:28-36.
3. Castilla LH, Couch FJ, Erdos MR, Hoskins KF, Calzone K, Garber JE, Boyd J, Lubin MB, Deshano ML, Brody LC, Collins F, Weber B (1994): Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer. Nat Genet 8:387-391.
4. De Souza AT, Yamada T, Mills JJ, Jirtle RL (1997): Imprinted genes in liver carcinogenesis. FASEB J 11:60-67.
5. Douc-Rasy S, Barrois M, Fogel S, Ahomadegbe JC, Stehelin D, Coll J, Riou G (1996): High incidence of loss of heterozygosity and abnormal imprinting of H19 and IGF2 genes in invasive cervical carcinomas: Uncoupling of H19 and IGF2 expression and biallelic hypomethylation of H19. Oncogene 12:423-430.
6. El-Roeiy A, Chen X, Roberts VJ, LeRoith D, Roberts CT Jr, Yen SSC (1993): Expression of insulin-like growth factor-I (IGF-I) and IGF-II and the IGF-I, IGF-II, and insulin receptor genes and localization of the gene products in the human ovary. J Clin Endocrinol Metab 77:14111418.
7. Enomoto T, Weghorst CM, Inoue M, Tanizawa O, Rice JM (1991): K-ras activation occurs frequently in mucinous adenocarcinomas and rarely in other common epithelial tumors of the human ovary. Am J Pathol 139:777-785.
8. Feinberg AP (1993): Genomic imprinting and gene activation in cancer. Nat Genet 4:110-113.
9. Hall JG (1990): Genomic imprinting review and relevance to human disease. Am J Hum Genet 46:857-873.
10. Hao Y, Crenshaw T, Moulton T, Newcomb E, Tycko B (1993): Tumor suppressor activity of H19 RNA. Nature 365:764-767.
11. Hashimoto K, Azuma C, Ohashi K, Kamiura S, Noburaga T, Kimura T, Tokugawa Y, Kanal T, Saji F (1995): Loss of imprinting in choriocarcinoma. Nat Genet 9:109-110.
12. Hibi K, Nakamura H, Hirai A, Fujikake Y, Kasai Y, Akiyama S, Ito K, Takagi H (1996): Loss of H19 imprinting in esophageal cancer. Cancer Res 56:480-482.
13. Kondo M, Suzuki H, Ueda R, Osada H, Takagi K, Takahashi T, Takahashi T (1995): Frequent loss of imprinting of H19 gene is often associated with its overexpression in human lung cancers. Oncogene 10:11931198.
14. Kupryjanczyk J, Bell DA, Dimeo D, Beauchamp R, Thor AD, Yandell DW (1995): p53 gene analysis of ovarian borderline tumors and stage I carcinomas. Hum Pathol 26:387-392.
15. Moulton T, Crenshaw T, Hao Y, Moosikasuwan J, Lin N, Dembitzer F, Hensle T, Weiss L, McMorrow L, Loew T, Krarus W, Gerald W, Tycko B (1994): Epigenetic lesions at the H19 locus in Wilms" tumour patients. Nat Genet 7:440-447.
16. Niikawa N (1996): Genomic imprinting and its relevance to genetic diseases. Jpn J Hum Genet 41:351-362.
17. Ogawa O, Eccles MR, Szeto J, McNoe LA, Yun K, Maw MA, Smith PJ, Reeve AE (1993): Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumor. Nature 362:749-751.
18. Okamoto K, Morison IM, Taniguchi T, Reeve AE (1997): Epigenetic changes at the insulin-like growth factor II/H19 locus in developing kidney is an early event in Wilms tumorigenesis. Proc Natl Acad Sei USA 94:5367-5371.
19. Pedone PV, Tirabosco R, Cavazzana AO, Ungaro P, Basso G, Luksch R, Carli M, Bruni CB, Frunzio R, Riccio A (1994): Mono- and bi-allelic expression of insulin-like growth factor II gene in human muscle tumors. Hum Mol Genet 3:1117-1121.
20. Rainier S, Johnson LA, Dobry CJ, Ping AJ, Grundy PE, Feinberg AP (1993): Relaxation of imprinted genes in human cancer. Nature 362: 747-749.
21. Steenman MJC, Rainier S, Dobry CJ, Grundy P, Horon IL, Feinberg AP (1994): Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumour. Nat Genet 7:433439.
22. Suzuki H, Ueda R, Takahashi T, Takahashi T (1994): Altered imprinting in lung cancer. Nat Genet 6:332-333.
23. Takeda S, Kondo M, Kumada T, Koshikawa T, Ueda R, Nishio M, Osada H, Suzuki H, Nagatake M, Washimi O, Takagi K, Takahashi T, Nakao A, Takahashi T (1996): Allelic-expression imbalance of the insulin-like growth factor 2 gene in hepatocellular carcinomas and underlying disease. Oncogene 12:1589-1592.
24. van Grup RJHLM, Oosterhuis JW, Kalscheuer V, Mariman ECM, Looijenga LHJ (1994): Biallelic expression of the H19 and IGF2 genes in human testicular germ cell tumors. J Natl Cancer Inst 86:1070-1075.
25. Viel A, Gianniai F, Tumiotto L, Sopracordevole F, Visentin MC, Boiocchi M (1992): Chromosomal localization of two putative lip oncosuppressor genes involved in human ovarian tumors. Br J Cancer 66:1030-1036.
26. Wilkins RJ (1988): Genomic imprinting and carcinogenesis. Lancet 1:329331.
27. Wu MS, Wang HP, Lin CG, Sheu JC, Shun CT, Lee WJ, Lin JT (1997): Loss of imprinting and overexpression of IGF2 gene in gastric adenocarcinoma. Cancer Lett 120:9-14.
28. Yu D, Wolf JK, Scanion M, Price JE, Hung MC (1993): Enhanced c-erbB2/neu expression in human ovarian cancer cells correlates with more severe malignancy that can be suppressed by E1A. Cancer Res 53:891898.
29. Yun K, Fukumoto M, Jinno Y (1996): Monoallelic expression of the insulinlike growth factor-2 gene in ovarian cancer. Am J Pathol 148:10811087.
30. Zhan S, Shapiro DN, Helman LJ (1995): Loss of imprinting of IGF2 in Ewing"s sarcoma. Oncogene 11:2503-2507.
31. Zhang Y, Tycko B (1992): Monoallelic expression of the human H19 gene. Nat Genet 1:40-44.